What is Dengue Vaccine?
Dengue vaccines are new. WHO recommends the TAK-003 vaccine (Qdenga) for children aged 6–16 in places with high dengue transmission. Preventing mosquito bites is still the main protection against dengue.
Dosage and schedule
Two doses, 3 months apart.
Who it's for
- Children aged 6–16 in areas with high dengue transmission (WHO recommendation)
Benefits
- WHO reports 84% protection against dengue hospital admission over 4.5 years in trials.
- Can be given to children who have never had dengue, unlike the older dengue vaccine.
Diseases prevented
- Dengue
Common reactions
- Pain or redness where the injection was given.
- Headache or muscle aches.
Precautions
- It is a live vaccine: not given in pregnancy or to people with a weakened immune system.
- WHO does not recommend it for children under 6.
- Keep using mosquito protection after vaccination.
When to seek help
- Seek care for difficulty breathing, swelling of the face or throat, or a high fever after vaccination.
